AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $56,525 | -74.8% | 78,736 | -20.4% | 0.00% | – |
Q4 2021 | $224,000 | -24.3% | 98,948 | -3.8% | 0.00% | – |
Q3 2021 | $296,000 | -17.8% | 102,890 | +8.4% | 0.00% | – |
Q2 2021 | $360,000 | +20.0% | 94,950 | +7.1% | 0.00% | – |
Q1 2021 | $300,000 | +18.6% | 88,665 | -2.0% | 0.00% | – |
Q4 2020 | $253,000 | +24.0% | 90,451 | +11.2% | 0.00% | – |
Q3 2020 | $204,000 | -79.3% | 81,345 | +5.0% | 0.00% | -100.0% |
Q2 2020 | $984,000 | +71.1% | 77,476 | +2.1% | 0.00% | 0.0% |
Q1 2020 | $575,000 | +26.4% | 75,862 | +5.5% | 0.00% | – |
Q4 2019 | $455,000 | +47.2% | 71,929 | -4.0% | 0.00% | – |
Q3 2019 | $309,000 | -14.9% | 74,931 | 0.0% | 0.00% | – |
Q2 2019 | $363,000 | -23.1% | 74,931 | +29.9% | 0.00% | -100.0% |
Q1 2019 | $472,000 | +53.2% | 57,669 | +3.6% | 0.00% | – |
Q4 2018 | $308,000 | -0.3% | 55,678 | +59.0% | 0.00% | – |
Q3 2018 | $309,000 | -22.6% | 35,024 | -12.3% | 0.00% | – |
Q2 2018 | $399,000 | +22.0% | 39,941 | +16.4% | 0.00% | – |
Q1 2018 | $327,000 | -36.6% | 34,321 | -1.2% | 0.00% | -100.0% |
Q4 2017 | $516,000 | -24.2% | 34,725 | +0.3% | 0.00% | 0.0% |
Q3 2017 | $681,000 | +59.5% | 34,632 | +16.5% | 0.00% | 0.0% |
Q2 2017 | $427,000 | +53.0% | 29,728 | -2.1% | 0.00% | – |
Q1 2017 | $279,000 | -0.7% | 30,379 | +12.4% | 0.00% | – |
Q4 2016 | $281,000 | +17.6% | 27,035 | +2.4% | 0.00% | – |
Q3 2016 | $239,000 | +21.9% | 26,406 | +0.4% | 0.00% | – |
Q2 2016 | $196,000 | +14.0% | 26,289 | +36.3% | 0.00% | – |
Q1 2016 | $172,000 | -23.9% | 19,289 | +10.2% | 0.00% | – |
Q4 2015 | $226,000 | +32.9% | 17,499 | 0.0% | 0.00% | – |
Q3 2015 | $170,000 | -5.0% | 17,499 | +0.6% | 0.00% | – |
Q2 2015 | $179,000 | +713.6% | 17,391 | +787.7% | 0.00% | – |
Q1 2015 | $22,000 | +22.2% | 1,959 | +22.9% | 0.00% | – |
Q4 2014 | $18,000 | -85.6% | 1,594 | -71.6% | 0.00% | – |
Q3 2014 | $125,000 | -13.2% | 5,616 | +8.5% | 0.00% | – |
Q2 2014 | $144,000 | – | 5,175 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
Leap Investments LP | 54,700 | $415,000 | 0.61% |